相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
A. S. Rosenberg et al.
BLOOD CANCER JOURNAL (2021)
Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma
Kalyan Nadiminti et al.
BLOOD CANCER JOURNAL (2021)
Second malignancies in multiple myeloma; emerging patterns and future directions
Kylee Maclachlan et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
Tarek H. Mouhieddine et al.
NATURE COMMUNICATIONS (2020)
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing
Shaji K. Kumar et al.
BLOOD (2019)
Ultra-Rapid Reporting of GENomic Targets (URGENTseq) Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection
Keyur P. Patel et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
Tomas Radivoyevitch et al.
LEUKEMIA RESEARCH (2018)
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J. Gibson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
Philip L. McCarthy et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Therapy-related myeloid neoplasms: when genetics and environment collide
Megan E. McNerney et al.
NATURE REVIEWS CANCER (2017)
Characteristics and Outcomes of Patients With Multiple Myeloma Who Develop Therapy-Related Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Naveen Pemmaraju et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years
Monika Engelhardt et al.
HAEMATOLOGICA (2015)
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years
Monika Engelhardt et al.
HAEMATOLOGICA (2015)
Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents
Morie A. Gertz et al.
LEUKEMIA & LYMPHOMA (2015)
Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data
Antonio Palumbo et al.
LANCET ONCOLOGY (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients
L. E. Roeker et al.
LEUKEMIA (2013)
Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics
P. Razavi et al.
BLOOD CANCER JOURNAL (2013)
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms
Eduard Schulz et al.
JOURNAL OF MEDICAL GENETICS (2012)
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Michel Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Philip L. McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
Sham Mailankody et al.
BLOOD (2011)
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
Yuan Xiao Zhu et al.
BLOOD (2011)
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
Mark R. Litzow et al.
BLOOD (2010)
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
H. Quach et al.
LEUKEMIA (2010)
Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms
C Dong et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
